TESAMORELIN

Tesamorelin is a synthetic analog of growth hormone-releasing hormone that keeps all 44 amino acids of the human sequence and adds a trans-3-hexenoic acid group at the N-terminus, the cap that slows enzymatic breakdown. It stimulates the pituitary's own growth hormone release rather than replacing the hormone. It's also the rare research peptide with a regulatory record: the FDA approved it in 2010, as Egrifta, for HIV-associated lipodystrophy, so labs studying tesamorelin peptides have more human data to work from than most GHRH analogs.

That same demand drives copies. A 2026 preprint by Mendias and Awan, covering 6,441 independent test reports, found 11 tesamorelin samples that didn't contain tesamorelin at all. The subtler failure is the missing cap: the hexenoyl group adds under 100 Da to a chain of more than 5,000, so an uncapped GHRH can sit right beside the real product on a chromatogram. Mass spectrometry separates them cleanly. Titan Core's tesamorelin is made in the USA, and an independent lab checks every batch by HPLC for purity and mass spectrometry for the complete molecule, hexenoyl cap included. The report you download here carries the same LOT number as your vial. It's supplied strictly for lab research, never for use in people or animals.